FDA
-
-
-
-
-
-
-
Axim International (AXIM) Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays
-
-
-
-
-
-
-
AXIM® Biotechnologies Receives Initial Order for Diagnostic Solutions as Exclusive Partner Verséa Ophthalmics Commences Initial Commercial Launch
-
-
-
-
-
-
-
AXIM Biotechnologies Completes Optimization of Only FDA-Cleared IgE Rapid Diagnostics Test – In-House Manufacturing Lowers Cost and Eliminates Supply Chain Expenditures
-
-
-
-
-
-
-
CDC Publishes AXIM® Biotechnologies-Sponsored Study on COVID-19 Neutralizing Antibodies
-
-
-
-
-
-
-
AXIM® Biotechnologies Appoints Leading US Ophthalmic Surgeon and Researcher Dr. Henry D. Perry to its Medical Advisory Board
-
-
-
-
-
-
-
AXIM® Biotechnologies Completes Pre-Clinical Drug Studies on SPX-1009 Compound Proving Suppression of Melanoma Cells
-
-
-
-
-
-
-
AXIM® Biotechnologies Completes Successful Covid-19 Live Virus Test and Files Amended EUA for Portable 10 Minute Rapid Diagnostic Test for Neutralizing Antibodies
-
328,335 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

